Search clinical trials for: Budesonide

Total 577 results

Air Force Military Medical University, China

Unknown

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (BTCOPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
King Saud University
King Fahad Medical City

Completed

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room

Status Asthmaticus

Saudi Arabia
AstraZeneca

Completed

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day (BAI)

Asthma

United States, Bulgaria, Hungary, Russian Federation
St. Paul's Hospital, Canada

Completed

Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray

Chronic Rhinosinusitis

Canada
Hospital Israelita Albert Einstein
Hospital M'Boi Mirim

Unknown

Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children (BUDEXA)

Stridor

Brazil
Research in Real-Life Ltd
Orion Corporation, Orion Pharma

Completed

Real Life Effectiveness of Easyhaler (Orion)

Asthma
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of Inhaled Treatment in Sinusitis

Sinusitis
University of California, San Francisco
Genentech, Inc.

Completed

Study of the Mechanisms of Asthma (MAST)

Asthma

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)

Asthma

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma

Asthma

United States
AstraZeneca

Completed

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy (CHASE 2)

Asthma

United States, South Africa, Hungary, Bulgaria, Czech Republic, Poland
Kuopio University Hospital

Completed

Saline Challenge in Monitoring Asthma Control

Asthma

Finland
Ioannis Koutsourelakis

Completed

Effect of Nasal Steroids in Snoring Intensity

Snoring

Greece
Mahidol University
National Science and Technology Development Agency, Thailand

Completed

Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

Thailand
AstraZeneca

Completed

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, France, Italy, Poland, Russian Federation, Ukraine, Hungary, Slovakia
Ataturk University

Completed

Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations

Chronic Obstructive Pulmonary Disease

Turkey
Saeed Abbasi

Unknown

Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit Patients

Respiratory Sounds

Iran, Islamic Republic of
Assistance Publique - Hôpitaux de Paris
AstraZeneca

Completed

Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT (Alloforb)

Obstructive Airway Disease

France
University of Bologna

Completed

Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children (SB-OSAS)

Obstructive Sleep Apnea Syndrome

Italy
Isfahan University of Medical Sciences

Unknown

Effect of Nebulized Budesonide on Preventing Postextubation Complications in Critically Patients

Respiratory Sounds

Iran, Islamic Republic of
Medical University of Lodz

Unknown

Effect of Montelukast in Asthma in Children

Bronchial Asthma

Poland
Temple University

Unknown

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Emphysema | Poor Sleep Quality

United States
Pharmaxis

Completed

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

Asthma

Canada
Pharmaxis

Completed

Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients

Copd Bronchitis

Canada
AstraZeneca

Completed

Study to Investigate the Efficacy of Symbicort® SMART. (SAKURA)

Asthma

Korea, Republic of, Peru, Philippines, China, Malaysia, Hungary, Japan, Argentina, Thailand, India, Brazil, Costa Rica
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (REFLI)

Asthma

Germany
Orion Corporation, Orion Pharma

Completed

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
University of Manitoba

Unknown

Hemifacial Spasm and Desflurane (HFS)

Hemifacial Spasm
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
AstraZeneca

Completed

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans (Titan)

Asthma

United States
AstraZeneca

Completed

Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma

Asthma

United States, United Kingdom
University of North Carolina, Chapel Hill
AstraZeneca

Completed

Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis

United States
AstraZeneca

Completed

A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.

Asthma

United States
AstraZeneca

Completed

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients (SUMIRE)

Chronic Obstructive Pulmonary Disease

Korea, Republic of, Poland, Russian Federation, Vietnam, Philippines, Ukraine, Japan, Taiwan, India
AstraZeneca

Completed

Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Turkey
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (ADECO)

Asthma

Germany
Ligand Pharmaceuticals

Completed

Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR

Seasonal Allergic Rhinitis

Canada
Ligand Pharmaceuticals

Completed

Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Assistance Publique - Hôpitaux de Paris

Completed

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation (alloforb)

Bronchiolitis Obliterans | Allogeneic Stem Cell Transplantation

France
AstraZeneca

Completed

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

COPD Method Evaluation | Chronic Obstructive Pulmonary Disease Method Evaluation

United Kingdom, Sweden
Ache Laboratorios Farmaceuticos S.A.

Completed

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma (Ach-ALN)

Asthma
AstraZeneca

Completed

Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD (CODEX)

Chronic Obstructive Pulmonary Disease

Germany, Switzerland
AstraZeneca

Completed

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide® (SPEED)

Chronic Obstructive Pulmonary Disease (COPD)

Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
AstraZeneca

Completed

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Asthma

Japan
AstraZeneca

Completed

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

Asthma

United States, Puerto Rico
AstraZeneca

Completed

Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma

Asthma

Japan
AstraZeneca

Completed

Symbicort Rapihaler Therapeutic Equivalence Study (ESTHER)

Bronchial Asthma

Bulgaria, Czech Republic, Poland, Hungary
AstraZeneca

Completed

Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients (MIA)

Exercise Induced Asthma

Sweden, Norway
AstraZeneca

Completed

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma (PASSION)

Asthma

Turkey

3

Subscribe